Liselotte Hyveled

Liselotte Hyveled is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as a Board Member at TriSalus Life Sciences since May 2024 and as Chief Patient Officer and Board Member at Novo Nordisk since August 1992. In the role of Chief Patient Officer, Liselotte Hyveled focuses on integrating patient needs into decision-making processes across the drug development value chain. Previous positions at Novo Nordisk include project and operational leadership roles related to drug development and clinical research, emphasizing innovative strategies and compliance. Liselotte Hyveled has also contributed to various boards and advisory positions, including serving as Chairman of the Danish Disability Council and as a life science startup advisor. Educated at prestigious institutions such as Harvard Business School and Copenhagen Business School, Liselotte Hyveled holds degrees in pharmacy and medical business strategies.